The Southeast Texas Hospice Medicare Approved Location: 912 West Cherry, Orange, Texas 77630 Phone: (409) 886-0622 |
News Archive
MHS Health Wisconsin, a wholly-owned subsidiary of Centene Corporation, presented its 7th Annual Summit Award to Maria Editha Bautista-Santos, MD, a family practice physician at Affinity Medical Group in Appleton, Wis.
Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer's Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.
A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and spreads.
A low level of response (LR) to alcohol reflects at least in part a low brain response to alcohol and carries significant risk for the later development of alcoholism. This study used functional magnetic resonance imaging (fMRI) to examine brain activation in individuals with low and high LRs to alcohol while they performed a cognitive task.
A drug approved by the Food and Drug Administration for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research from the Icahn School of Medicine at Mount Sinai.
› Verified 9 days ago